| Primary |
| Insomnia |
32.7% |
| Drug Use For Unknown Indication |
16.9% |
| Sleep Disorder |
9.5% |
| Hypertension |
7.8% |
| Ill-defined Disorder |
6.2% |
| Schizophrenia |
4.1% |
| Depression |
3.7% |
| Anxiety |
3.1% |
| Pain |
2.9% |
| Suicide Attempt |
2.9% |
| Alcoholism |
1.2% |
| Osteoporosis |
1.2% |
| Personality Disorder |
1.2% |
| Restlessness |
1.2% |
| Reflux Oesophagitis |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Back Pain |
0.8% |
| Diabetes Mellitus |
0.8% |
| Gastric Ulcer |
0.8% |
| Gastritis |
0.8% |
|
| Suicide Attempt |
29.8% |
| Overdose |
8.6% |
| Somnolence |
7.1% |
| Road Traffic Accident |
5.9% |
| Loss Of Consciousness |
5.1% |
| Delirium |
4.3% |
| Drug Ineffective |
4.3% |
| Rhabdomyolysis |
3.9% |
| Death |
3.5% |
| Intentional Overdose |
3.5% |
| Restlessness |
3.1% |
| Completed Suicide |
2.7% |
| White Blood Cell Count Increased |
2.7% |
| Respiratory Depression |
2.4% |
| Sopor |
2.4% |
| Toxicity To Various Agents |
2.4% |
| Withdrawal Syndrome |
2.4% |
| Dementia |
2.0% |
| Hepatic Function Abnormal |
2.0% |
| Multiple Drug Overdose |
2.0% |
|
| Secondary |
| Insomnia |
22.9% |
| Product Used For Unknown Indication |
12.0% |
| Depression |
8.9% |
| Drug Use For Unknown Indication |
8.8% |
| Anxiety |
6.6% |
| Drug Exposure During Pregnancy |
5.9% |
| Hypertension |
4.2% |
| Schizophrenia |
4.2% |
| Schizophrenia, Paranoid Type |
3.7% |
| Constipation |
2.5% |
| Ill-defined Disorder |
2.5% |
| Pain |
2.5% |
| Sleep Disorder |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Bipolar Disorder |
1.8% |
| Duodenal Ulcer Perforation |
1.8% |
| Major Depression |
1.8% |
| Rectal Cancer Metastatic |
1.8% |
| Road Traffic Accident |
1.8% |
| Diabetes Mellitus |
1.6% |
|
| Vomiting |
14.0% |
| Overdose |
8.3% |
| Suicide Attempt |
8.3% |
| Sopor |
7.4% |
| Delirium |
5.8% |
| Hallucination |
5.8% |
| Somnolence |
5.8% |
| Liver Disorder |
5.0% |
| Pyrexia |
5.0% |
| Toxic Epidermal Necrolysis |
5.0% |
| Hepatic Function Abnormal |
3.3% |
| Jaundice |
3.3% |
| Loss Of Consciousness |
3.3% |
| Shock |
3.3% |
| Treatment Noncompliance |
3.3% |
| Visual Field Defect |
3.3% |
| Abnormal Behaviour |
2.5% |
| Blepharospasm |
2.5% |
| Completed Suicide |
2.5% |
| Drug Abuse |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.8% |
| Insomnia |
12.7% |
| Product Used For Unknown Indication |
12.7% |
| Hypertension |
8.5% |
| Depression |
7.2% |
| Rheumatoid Arthritis |
6.3% |
| Diffuse Large B-cell Lymphoma |
4.8% |
| Prophylaxis |
3.6% |
| Constipation |
3.1% |
| Gastritis |
2.5% |
| Diabetes Mellitus |
2.4% |
| Pain |
2.3% |
| Schizophrenia |
2.0% |
| Hepatitis C |
1.9% |
| Sleep Disorder |
1.9% |
| Osteoporosis |
1.7% |
| Anxiety |
1.6% |
| Hyperlipidaemia |
1.5% |
| Colitis Ulcerative |
1.3% |
| Type 2 Diabetes Mellitus |
1.1% |
|
| Vomiting |
9.7% |
| Pyrexia |
8.7% |
| White Blood Cell Count Decreased |
6.6% |
| Hepatic Function Abnormal |
5.8% |
| Liver Disorder |
5.2% |
| Somnolence |
5.2% |
| Suicide Attempt |
5.2% |
| Weight Decreased |
5.2% |
| Rash |
5.0% |
| Nausea |
4.9% |
| Renal Failure Acute |
4.9% |
| Rhabdomyolysis |
4.9% |
| Tremor |
4.9% |
| Renal Impairment |
4.5% |
| Pneumonia |
3.9% |
| Interstitial Lung Disease |
3.4% |
| Weight Increased |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Renal Failure |
2.9% |
| Death |
2.8% |
|
| Interacting |
| Insomnia |
22.9% |
| Pain |
20.0% |
| Back Pain |
11.4% |
| Cardiac Disorder |
11.4% |
| Hypertension |
8.6% |
| Depression |
5.7% |
| Gastritis |
5.7% |
| Neuralgia |
5.7% |
| Constipation |
2.9% |
| Oral Candidiasis |
2.9% |
| Rhinitis Allergic |
2.9% |
|
| Drug Interaction |
30.0% |
| Drug Ineffective |
20.0% |
| Dysstasia |
10.0% |
| Hallucination |
10.0% |
| Potentiating Drug Interaction |
10.0% |
| Somnolence |
10.0% |
| Visual Acuity Reduced |
10.0% |
|
